FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 47 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $12,099,000 | -17.2% | 1,154,476 | -7.0% | 0.31% | -29.4% |
| Q1 2021 | $14,621,000 | +0.6% | 1,241,176 | 0.0% | 0.44% | +0.9% |
| Q4 2020 | $14,534,000 | +27.2% | 1,241,176 | -13.9% | 0.43% | -15.8% |
| Q3 2020 | $11,429,000 | -56.6% | 1,441,176 | 0.0% | 0.51% | -67.2% |
| Q2 2020 | $26,359,000 | +82.6% | 1,441,176 | +19.2% | 1.56% | +1.8% |
| Q1 2020 | $14,439,000 | -30.0% | 1,209,285 | -2.4% | 1.53% | -19.1% |
| Q4 2019 | $20,622,000 | -99.6% | 1,239,285 | +46.8% | 1.90% | +226.9% |
| Q3 2019 | $5,606,052,000 | – | 844,285 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |